Fatal atypical reversible posterior leukoencephalopathy syndrome: a case report
© Golombeck et al.; licensee BioMed Central Ltd. 2013
Received: 17 July 2012
Accepted: 8 November 2012
Published: 10 January 2013
Reversible posterior leukoencephalopathy syndrome – a reversible subacute global encephalopathy clinically presenting with headache, altered mental status, visual symptoms such as hemianopsia or cortical blindness, motor symptoms, and focal or generalized seizures – is characterized by a subcortical vasogenic edema symmetrically affecting posterior brain regions. Complete reversibility of both clinical signs and magnetic resonance imaging lesions is regarded as a defining feature of reversible posterior leukoencephalopathy syndrome. Reversible posterior leukoencephalopathy syndrome is almost exclusively seen in the setting of a predisposing clinical condition, such as pre-eclampsia, systemic infections, sepsis and shock, certain autoimmune diseases, various malignancies and cytotoxic chemotherapy, transplantation and concomitant immunosuppression (especially with calcineurin inhibitors) as well as episodes of abrupt hypertension. We describe for the first time clinical, radiological and histological findings in a case of reversible posterior leukoencephalopathy syndrome with an irreversible and fatal outcome occurring in the absence of any of the known predisposing clinical conditions except for a hypertensive episode.
A 58-year-old Caucasian woman presented with a two-week history of subacute and progressive occipital headache, blurred vision and imbalance of gait and with no evidence for raised arterial blood pressure during the two weeks previous to admission. Her past medical history was unremarkable except for controlled arterial hypertension. Cerebral magnetic resonance imaging demonstrated cortical and subcortical lesions with combined vasogenic and cytotoxic edema atypical for both venous congestion and arterial infarction. Routine laboratory and cerebrospinal fluid parameters were normal. The diagnosis of reversible posterior leukoencephalopathy syndrome was established.
Within hours after admission the patient showed a rapidly decreasing level of consciousness, extension and flexion synergisms, bilaterally extensor plantar responses and rapid cardiopulmonary decompensation requiring ventilatory and cardiocirculatory support. Follow-up cerebral imaging demonstrated widespread and confluent cytotoxic edematous lesions in different arterial territories, global cerebral swelling, and subsequent upper and lower brainstem herniation. Four days after admission, the patient was declared dead because of brain death.
This case demonstrates that fulminant and fatal reversible posterior leukoencephalopathy syndrome may occur spontaneously, that is, in the absence of any of the known predisposing systemic conditions.
KeywordsBlood pressure Cerebral autoregulation Generalized cerebral edema Reversible posterior leukoencephalopathy syndrome
In 1996 Hinchey et al.  described reversible posterior leukoencephalopathy syndrome (RPLS): a reversible subacute global encephalopathy clinically presenting with headache, altered mental status, visual symptoms (hemianopsia or cortical blindness), motor symptoms, and focal or generalized seizures [1–4]. The characteristic neuroimaging feature in classical RPLS is a partially or completely reversible subcortical vasogenic edema (leukoencephalopathy) symmetrically affecting the posterior (parietal and occipital) brain regions [1, 2, 4, 5]. Magnetic resonance imaging (MRI) exhibits transient signal alterations indicative of vasogenic edema [6, 7]. By contrast, persisting signal alterations indicating cytotoxic edema due to secondary infarction are uncommon initial findings in RPLS [2, 5]. RPLS is almost exclusively seen in the setting of a predisposing clinical condition, such as pre-eclampsia, systemic infections, sepsis and shock, certain autoimmune diseases, various malignancies, chemotherapy, transplantation and concomitant immunosuppression (especially with calcineurin inhibitors) as well as episodes of abrupt hypertension [2, 4].
Except for initial arterial hypertension (mean arterial blood pressure of about 130mmHg) the mean arterial blood pressure was kept well below 110mmHg by antihypertensive therapy. Cerebral vascular ultrasound, echocardiographic examination and continuous electrocardiography did not show any abnormalities. Routine laboratory parameters and parameters indicating a hypercoagulable state or vasculitis were normal as was routine cerebrospinal fluid analysis.
Within hours after admission the patient showed a rapidly decreasing level of consciousness, extension and flexion synergisms, bilaterally extensor plantar responses and rapid cardiopulmonary decompensation requiring ventilatory and cardiocirculatory support. Follow-up MRI two days after admission demonstrated more widespread and confluent cytotoxic edematous lesions in different arterial territories clearly exceeding the vertebrobasilar territory (Figure 1F–H), hemorrhagic transformation (Figure 1J) and mild contrast enhancement (Figure 1I). Of importance, at this time there was no evidence of thrombosis of the cerebral sinus and veins or arterial occlusion.
By contrast, three days after admission follow-up CT revealed global cerebral swelling, subsequent upper and lower brainstem herniation and brainstem compression as well as generalized thrombosis of the cerebral sinus and veins (Figure 1L). Four days after admission, the patient was declared dead because of brain death.
Controversy exists about the mechanism underlying RPLS: (1) severe hypertension exceeding the upper limit of cerebral vascular autoregulation leading to reversible cerebral vasogenic edema [2, 5, 8] or (2) mild-to-moderate hypertension in the presence of a predisposing systemic condition leading to enhanced cerebral autoregulatory vasoconstriction and subsequent brain edema .
In our case, none of the predisposing systemic conditions were present and hypertension never exceeded the upper limit of cerebral vascular autoregulation (corresponding to a mean arterial pressure of 150–160mmHg in normotensive individuals), especially as there was chronic arterial hypertension, known to shift the upper limit of autoregulation of cerebral blood flow towards higher values [2, 5, 8]. Moreover, as the initially affected brain areas are not drained by deep cerebral veins, occult sinus vein thrombosis seems unlikely as an initiating event. Further, formation of widespread confluent cytotoxic edematous lesions occurred well before secondary thrombosis of cerebral sinus and veins became evident.
Our case demonstrates that fulminant and fatal RPLS may occur spontaneously, that is, in the absence of any of the known predisposing systemic conditions.
Written informed consent was obtained from the patient’s next of kin for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
fluid-attenuated inversion recovery
Reversible posterior leukoencephalopathy syndrome
- Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR: A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996, 334 (8): 494-500. 10.1056/NEJM199602223340803.View ArticlePubMed
- Bartynski WS: Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008, 29 (6): 1036-1042. 10.3174/ajnr.A0928.View ArticlePubMed
- Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW: Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol. 2008, 29 (5): 924-930. 10.3174/ajnr.A0960.View ArticlePubMed
- Lee VH, Wijdicks EF, Manno EM, Rabinstein AA: Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008, 65 (2): 205-210. 10.1001/archneurol.2007.46.View ArticlePubMed
- Feske SK: Posterior reversible encephalopathy syndrome: a review. Semin Neurol. 2011, 31 (2): 202-215. 10.1055/s-0031-1277990.View ArticlePubMed
- Psychogios MN, Schramm P, Knauth M: [Reversible encephalopathy syndrome, RES or PRES: a case with more W (watershed) than P (posterior)!] [Article in German]. Rofo. 2010, 182 (1): 76-79. 10.1055/s-0028-1109778.View ArticlePubMed
- Doelken M, Lanz S, Rennert J, Alibek S, Richter G, Doerfler A: Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI. Diagn Interv Radiol. 2007, 13 (3): 125-128.PubMed
- Bartynski WS: Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008, 29 (6): 1043-1049. 10.3174/ajnr.A0929.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.